Radioactive Strontium-89 for Painful Bone Metastases
Strontium-89 chloride was recently approved for marketing by the US Food and Drug Administration. It is offered for relief of pain caused by metastatic bone lesions...
Cannot Access - We are sorry, but you cannot access the requested article.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
If you have already purchased this article, or have a subscription to The Medical Letter on Drugs and Therapeutics, please login or register to view it online.
Information about the article:
Title: Radioactive Strontium-89 for Painful Bone Metastases
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 908
Article Code: 908b
Date: October 29, 1993
Volume: 35
Page: 102
Publication: The Medical Letter on Drugs and Therapeutics
Issue #: 908
Article Code: 908b
Date: October 29, 1993
Volume: 35
Page: 102
Subscribe to The Medical Letter on Drugs and Therapeutics for instant access to this article. Add this downloadable, electronic article to your cart (U.S. English version only)